Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma (Q40155012)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 November 2007

Language	Label	Description	Also known as
English	Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma	scientific article published on 12 November 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

phase II clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Dimitri Flieger

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Christine Klassert

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sabine Hainke

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Ralf Keller

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Rolf Kleinschmidt

5

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Wolfgang Fischbach

6

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

12 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

72

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

10-16

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

The camptothecins.

1 reference

https://api.crossref.org/works/10.1159%2F000111083

21 January 2018

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000111083

21 January 2018

Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum

1 reference

https://api.crossref.org/works/10.1159%2F000111083

21 January 2018

Prevention of irinotecan-induced diarrhea by oral sodium bicarbonate and influence on pharmacokinetics

1 reference

https://api.crossref.org/works/10.1159%2F000111083

21 January 2018

Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1159%2F000111083

21 January 2018

Identifiers

10.1159/000111083

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40155012&oldid=1887421498"